web statistics
PRESS ROOM        PUBLICATIONS       CAREERS
KineMed  ► About > Press Room > KineMed Announces Agreement with Amgen to Develop Kinetic Biomarkers of Brain Proteinopathies

News & Press Room

Forthcoming Events


KineMed Data to be Presented at the American Society of Hematology Meeting in San Francisco, California, December 6-9

Presentation details:

Elizabeth J. Murphy, MD, DPhil, from the University of California San Francisco Department of Medicine, and representing the CLL Research Consortium investigators, will give the presentation titled “CLL: Biology and Pathophysiology, Excluding Therapy: Novel Prognosticator and Therapeutic Targets”. The presentation will take place Tuesday, December 9, 2014 at 7:30 AM PST, in the South Building, Esplanade 302, of the Moscone Center.

Jan A. Burger, MD, Ph.D., of the MD Anderson Cancer Center will give the presentation titled “CLL: Therapy, Excluding Transplantation: Novel Therapeutics”. The presentation will take place take place Monday, December 8th, 7:15 AM PST, in the West Building, 3001-3003-3014-3016, of the Moscone Center.

Latest News

KineMed Announces Agreement with Amgen to Develop Kinetic Biomarkers of Brain Proteinopathies

KineMed Announces Agreement with Amgen to Develop Kinetic Biomarkers of Brain Proteinopathies

Presentations & Webcasts



 

Press & Public Relations Contact

We are always pleased to assist the press with queries about KineMed. Please visit our press contact page for more information.

Please Contact Us ‣‣

FUNCTIONALLY INTERPRETABLE BIOMARKERS FOR THE NEXT GENERATION OF DISEASE MANAGEMENT

Mr David Fineman  |  President & CEO

Download


5980 Horton Street | Suite 470 | Emeryville, CA 94608 | Tel.: USA [1] 510.655.6525 | Fax: [1] 510.655.6506 | TOLL-FREE: 855.KINEMED | E-mail: info@kinemed.com

 Copyright © 2013 KineMed, Inc.  |  All Rights Reserved  |  Privacy  |  Terms & Conditions